Trials / Completed
CompletedNCT03428997
Human Comedogenicity Test
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Johnson & Johnson Consumer Inc. (J&JCI) · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Testing comedogenicity potential of a device cream on humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lotion | Formulated Lotion F# 13451-131 was applied on an occlusive patch and placed on a test site on each subjects back three times a week for four weeks. |
| OTHER | Negative Control | Control. An undosed occlusive patch was placed on a test site on each subjects back three times a week for four weeks. |
Timeline
- Start date
- 2017-11-20
- Primary completion
- 2018-02-05
- Completion
- 2018-02-05
- First posted
- 2018-02-12
- Last updated
- 2023-07-03
- Results posted
- 2019-08-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03428997. Inclusion in this directory is not an endorsement.